Pathyaപഥ്യം
← New record

IndiPGx-Pop p097

Lab reportcohort · india-sim

10/30/2026, 1:55:52 PM · PharmCAT 3.4.0 · Research record, not medical advice

5
Genes standardised
5
Calls quoted
0
Coverage gaps
0
Identifiers removed
22.4s
Upload to record
  1. Muse Sparkread 5 gene calls11.3s
  2. PharmCATstandardised 5 genes11.1s
  3. Rules0 coverage gaps

CallsMuse Spark each call quoted from the source, then standardised by PharmCAT

Sample Molecular Diagnostics, Bengaluru · NOT A REAL LAB · 24 Oct 2026 · open original photo

Uploaded lab report photo
GeneAs printedStandardisedPhenotype term
CYP2C19“CYP2C19 rs4244285 G/A Heterozygous; CYP2C19 rs4986893 G/G Wild type; CYP2C19 rs12248560 C/C Wild type”*1/*2Intermediate Metabolizer
DPYD“DPYD rs75017182 C/C Wild type; DPYD rs1801265 A/A Wild type; DPYD rs3918290 C/C Wild type; DPYD rs55886062 A/A Wild type; DPYD rs67376798 T/T Wild type”Reference/ReferenceNormal Metabolizer · activity 2.0
NUDT15“NUDT15 rs116855232 C/C Wild type”*1/*1Normal Metabolizer
TPMT“TPMT rs1142345 A/A Wild type; TPMT rs1800460 C/C Wild type”*1/*1Normal Metabolizer
UGT1A1“UGT1A1 rs3064744 (TA)6/(TA)7 Heterozygous; UGT1A1 rs4148323 G/G Wild type”*1/*28Intermediate Metabolizer

Method as printed: Method: targeted genotyping by real-time PCR. Only the listed variants are assayed; variants outside this panel cannot be excluded. Genotypes are reported per rsID on the forward strand. Star-allele assignment is left to the treating clinician.

Coveragedeterministic rules · which India-relevant variants this panel named

DPYDHapB3named on the report

Most common Indian decreased-function DPYD variant (~3.3%, PMID 40810747)

DPYDc.85T>C (*9A)named on the report

~25% in Indians; toxicity signal in South Indian cohorts (PMC11300675)

DPYD*2Anamed on the report

European tier-1 variant; rare in Indians (PMID 40810747)

DPYD*13named on the report

Tier-1 no-function variant (PMID 39032821)

DPYDc.2846A>Tnamed on the report

Tier-1 variant; near-absent in Indians (PMID 40810747)

NUDT15*3named on the report

Main NUDT15 risk allele, ~7-11% in Indians (PMID 29470173)

UGT1A1*28named on the report

TA-repeat allele, common in South Asians

UGT1A1*6named on the report

East Asian allele; reported at low frequency in India

TPMT*3Cnamed on the report

Most common TPMT variant in South Asians

CYP2C19*2named on the report

Common no-function allele in South Asians

CYP2C19*17named on the report

Increased-function allele

A variant the panel did not name is left out of cohort statistics for that variant, rather than counted as absent. Reader notes: Only the listed variants are assayed; variants outside this panel cannot be excluded. Star-allele assignment is left to the treating clinician. Synthetic document generated for software benchmarking. Not a real patient or laboratory.

Exportde-identified · the same record in three formats

Curator review

A curator checks each call against the source document before the record counts in a cohort, and Muse Spark web search finds published Indian frequency data for each variant. Both are written to the audit log. Reviewing is the one action that needs a curator code, because it is a claim that a person checked the page.

Sign in as a curator
Research tool, not medical advice. Pathya reads and standardises pharmacogenomic results; it makes no dose, drug or test recommendation. Audit log: data/cases/33095da3ecf3/audit.log.